Form 4 for BDX Becton Dickinson
Accepted 2026-01-28 00:00:00 ET · period of report 2026-01-26 · accession 0001628280-26-003734 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-28 | 2026-01-26 | BDX | Feld Michael | EVP, CRO, Pres. Life Sciences | S - Sale | $202.73 | -75 | 16.4K | -0.5% | -$15.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-26 | S | D | 75 | $202.73 | 16,431 | D | — | — |